We want to ensure optimum use of our website for you, and to continually improve our website. Therefore, we work with selected partners (e.g. Pardot, Google Analytics, Matomo). You can revoke your voluntary consent at any time. You can find further information and setting options under "Configure" and in our data protection information.
Painless, Non-Surgical Non-Melanoma Skin Cancer Treatment (NMSC)
Explore Skin eBx
From a leading provider of electronic brachytherapy, skin eBx provides an effective, non-surgical,
convenient treatment option with excellent clinical and cosmetic results for appropriately selected
patients.1
Elekta Xoft offers patients and physicians a non-invasive alternative to surgery for NMSC treatment. With
Elekta Xoft, painless, scar-free treatment of NMSC is possible with skin eBx, a form of high dose rate, low
energy radiation therapy delivered in minutes over a short series of office visits.
While Mohs surgery is considered to be the standard of care for NMSC treatment, for some patients, surgery
is not an option or a preference.
Skin eBx is particularly ideal in treating anatomically challenging locations, such as the face, scalp,
nose, ears, arms and legs, as well as areas prone to difficulties in wound healing. Skin eBx may also be the
preferred option for patients who are not surgical candidates due to medical comorbidities, or patients with
higher-risk lesions requiring adjunct therapy to surgery. Other skin indications such as keloids are also
suitable for treatment with skin eBx.
References
A Bhatnagar, et al. High-dose Rate Electronic Brachytherapy: A Nonsurgical Treatment Alternative
for Nonmelanoma Skin Cancer. The Journal of Clinical and Aesthetic Dermatology; Nov. 2016; Vol. 9;
No.11: 16-22.
Why eBx?
Targeted
A miniaturized x-ray source delivers a precise dose of radiation directly to the cancerous site. This focused approach carefully destroys cancer cells and spares surrounding healthy tissue.
Convenient
By offering an in-office option for NMSC treatment, skin eBx allows patients to return to normal activities immediately with no downtime.
Non-surgical
Skin eBx is painless, scar-free and does not require anesthesia, offering a patient-friendly solution.
Efficient
Our skin eBx platform comprised of cutting-edge hardware and software was expertly designed to facilitate best in class clinical collaboration and quality of care.
Expanding patient-centric options for value-based care
Expanding patient-centric options for value-based care
Right antihelix
Squamous cell carcinoma treated with 40 Gy to a 3 mm depth
Right upper eyelid
Basal cell carcinoma treated with 40 Gy to a 3 mm depth
Left cheek
Squamous cell carcinoma treated with 40 Gy to a 5 mm depth
Left tip of nose
Basal cell carcinoma treated with 40 Gy to a 3 mm depth
1: Lesion at baseline, 2: 1-year follow up, 3: 23-month follow up
Images courtesy of Ajay Bhatnagar, MD, MBA, Casa Grande, AZ
We recently decided to adopt Elekta Xoft because it is a clinically proven treatment option for NMSC that offers patients the ability to complete a course of therapy in fewer treatments, compared to alternative treatments. While Mohs surgery certainly has a high cure rate, there are some patients for whom Xoft Skin eBx may be more suitable. For example, patients who are on blood thinners, or who have lesions in difficult-to-treat areas, such as the face, head, or neck. Patients with multiple NMSC lesions may also just reach a point of excision fatigue, and in these cases, they may prefer Xoft skin eBx, as it offers a painless, noninvasive approach to treatment, which yields excellent clinical and cosmetic results.”
A miniaturized x-ray source delivers a precise dose of radiation directly to the cancerous site. This focused approach carefully destroys cancer cells and spares surrounding healthy tissue.
Specifically designed and wirelessly optimized for surface treatments, the Axxent SPX controller provides physicians with improved flexibility and scalability to treat NMSC lesions in a broader range of treatment environments.
The Axxent extended balloon applicators are a key component of Elekta Xoft, empowering targeted delivery of intracavitary and intraoperative radiation therapy.
The Axxent® vaginal applicators are a key component of the Xoft® Axxent® Electronic Brachytherapy (eBx®) System®, empowering targeted brachytherapy in the vagina and rectum.
The Axxent cervical applicator is a key component of the Xoft® Axxent® Electronic Brachytherapy (eBx®) System®, empowering targeted intracavitary treatment of cancer of the uterus, cervix, endometrium and vagina.
